It is well established that correct glycosylation of glycoproteins and glycolipids is fundamental to normal development and maintenance of higher animals. However, little is known about the structural and functional relationship of the oligosaccharide chains and the regulation of their expression. Among the sugars that comprise the carbohydrate chains, sialic acid, present only as the terminal sugars, is perhaps the most extensively, albeit incompletely, studied. It is the long ranged goal of this project to elucidate the pathways that determine the tissue and development specificities of sialic acid moieties on glycoconjugates. At least five, and most likely more, sialytransferases are required in the biosynthesis of the major sialic acid linkages found in mammalian glycoproteins. However, previous analysis of the functionality of sialic acids and the regulated expression of sialytransferases has been hampered by lack of sequence information from which specific molecular probes can be constructed. Efforts from this and other laboratories resulted in the sequence elucidation of the hepatic beta-galactoside alpha2,6- sialytransferase mRNA is modulated via the glucocorticoid pathway. Current observations from this laboratory has also uncovered a family of transcripts closely related to the hepatic alpha2,6-sialytransferase mRNA and exhibit a tissue specific pattern of expression. At least on of these related transcripts putatively encodes a divergent polypeptide sequence. An immediate objective of this study is a detailed characterization of the different members of this family and an assessment of the relationship and genetic origin of the individual transcripts. Subsequently, the functionality as well as in vivo and in vitro patterns of synthesis of these transcripts and polypeptides will be addressed. A parallel goal of this study is the elucidation of regulatory pathways that govern the expression of this family of sialytransferase related transcripts. To this end, requisite regulatory sequences will be identified and tested by the expression of chimeric constructs.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM038193-07
Application #
3294341
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1987-04-01
Project End
1995-03-31
Budget Start
1993-04-01
Budget End
1994-03-31
Support Year
7
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Appenheimer, Michelle M; Huang, Ruea-Yea; Chandrasekaran, E V et al. (2003) Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase. Glycobiology 13:591-600
Wuensch, S A; Huang, R Y; Ewing, J et al. (2000) Murine B cell differentiation is accompanied by programmed expression of multiple novel beta-galactoside alpha2, 6-sialyltransferase mRNA forms. Glycobiology 10:67-75
Dimitroff, C J; Pera, P; Dall'Olio, F et al. (1999) Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells. Biochem Biophys Res Commun 256:631-6
Dall'Olio, F; Chiricolo, M; Lau, J T (1999) Differential expression of the hepatic transcript of beta-galactoside alpha2,6-sialyltransferase in human colon cancer cell lines. Int J Cancer 81:243-7
Lo, N W; Dennis, J W; Lau, J T (1999) Overexpression of the alpha2,6-sialyltransferase, ST6Gal I, in a low metastatic variant of a murine lymphoblastoid cell line is associated with appearance of a unique ST6Gal I mRNA. Biochem Biophys Res Commun 264:619-21
Dalziel, M; Lemaire, S; Ewing, J et al. (1999) Hepatic acute phase induction of murine beta-galactoside alpha 2,6 sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts. Glycobiology 9:1003-8
Lo, N W; Lau, J T (1999) Transcription of the beta-galactoside alpha2,6-sialyltransferase gene (SIAT1) in B-lymphocytes: cell type-specific expression correlates with presence of the divergent 5'-untranslated sequence. Glycobiology 9:907-14
Kalcheva, I; Elliott, R W; Dalziel, M et al. (1997) The gene encoding beta-galactoside alpha2,6-sialyltransferase maps to mouse chromosome 16. Mamm Genome 8:619-20
Hu, Y P; Dalziel, M; Lau, J T (1997) Murine hepatic beta-galactoside alpha 2,6-sialyltransferase gene expression involves usage of a novel upstream exon region. Glycoconj J 14:407-11
Dall'Olio, F; Mariani, E; Tarozzi, A et al. (1997) Expression of beta-galactoside alpha 2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis. Glycobiology 7:507-13

Showing the most recent 10 out of 24 publications